Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Robert Califf
Biotech
Vanda’s CEO pens searing letter to FDA’s Califf after rejection
After receiving an FDA rejection last fall, Vanda CEO Mihael Polymeropoulos is criticizing the agency's “disturbing pattern of conduct."
Gabrielle Masson
Jan 9, 2025 10:51am
FDA wants to hear from you on future of adcomm meetings
Apr 29, 2024 12:51pm
Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders
Jan 12, 2024 9:30am
Accelerated approval reforms land in Congress' spending bill
Dec 20, 2022 11:31am
Califf pushes for trial diversity ahead of new FDA guidance
Dec 8, 2022 11:28am
FDA looks to bypass cancer drugs' companion diagnostics: Pazdur
Nov 18, 2022 9:17am
